Terms: = Breast cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359 AND Diagnosis
21 results:
1. Whole-Genome Sequencing Analysis of Male breast cancer Unveils Novel Structural Events and Potential Therapeutic Targets.
Al Assaad M; Michaud O; Semaan A; Sigouros M; Tranquille M; Phan A; Levine MF; Gundem G; Medina-Martínez JS; Papaemmanuil E; Manohar J; Wilkes D; Sboner A; Hoda SAF; Elemento O; Mosquera JM
Mod Pathol; 2024 Apr; 37(4):100452. PubMed ID: 38369186
[TBL] [Abstract] [Full Text] [Related]
2. Clinical and imaging modality factors impacting radiological interpretation of breast screening in young women with neurofibromatosis type 1.
Wilding M; Fleming J; Moore K; Crook A; Reddy R; Choi S; Schlub TE; Field M; Thiyagarajan L; Thompson J; Berman Y
Fam Cancer; 2023 Oct; 22(4):499-511. PubMed ID: 37335380
[TBL] [Abstract] [Full Text] [Related]
3. Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
Bychkovsky BL; Lo MT; Yussuf A; Horton C; Hemyari P; LaDuca H; Garber JE; Scheib R; Rana HQ
Breast Cancer Res Treat; 2023 Jul; 200(1):63-72. PubMed ID: 36856935
[TBL] [Abstract] [Full Text] [Related]
4. Lymphomas in patients with neurofibromatosis type 1 (nf1): another malignancy in the nf1 syndrome?
Fareez F; Wang BH; Brain I; Lu JQ
Pathology; 2023 Apr; 55(3):302-314. PubMed ID: 36774237
[TBL] [Abstract] [Full Text] [Related]
5. Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
Musacchio L; Califano D; Bartoletti M; Arenare L; Lorusso D; Losito NS; Cormio G; Greggi S; Raspagliesi F; Valabrega G; Salutari V; Pisano C; Spina A; Russo D; Del Sesto M; Canzonieri V; Ferraù F; Zannoni GF; Loizzi V; Ghizzoni V; Casanova C; Tuninetti V; Ducceschi M; Del Vecchio V; Scalone S; Priolo D; Perrone F; Scambia G; Pignata S
Br J Cancer; 2022 Nov; 127(8):1479-1486. PubMed ID: 35869143
[TBL] [Abstract] [Full Text] [Related]
6. Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics.
Bychkovsky BL; Lo MT; Yussuf A; Horton C; Richardson M; LaDuca H; Garber JE; Rana HQ
Cancer; 2022 Mar; 128(6):1275-1283. PubMed ID: 34875721
[TBL] [Abstract] [Full Text] [Related]
7. Familial wild-type gastrointestinal stromal tumour in association with germline truncating variants in both SDHA and PALB2.
Whitworth J; Casey RT; Smith PS; Giger O; Martin JE; Clark G; Cook J; Fernando MS; Taniere P; ; Maher ER
Eur J Hum Genet; 2021 Jul; 29(7):1139-1145. PubMed ID: 33854214
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic cancer Center vs in the General Population From 1985 to 2020.
Landry JP; Schertz KL; Chiang YJ; Bhalla AD; Yi M; Keung EZ; Scally CP; Feig BW; Hunt KK; Roland CL; Guadagnolo A; Bishop AJ; Lazar AJ; Slopis JM; McCutcheon IE; Torres KE
JAMA Netw Open; 2021 Mar; 4(3):e210945. PubMed ID: 33734413
[TBL] [Abstract] [Full Text] [Related]
9. Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome.
Ferrer-Avargues R; Castillejo MI; Dámaso E; Díez-Obrero V; Garrigos N; Molina T; Codoñer-Alejos A; Segura Á; Sánchez-Heras AB; Castillejo A; Soto JL
Cancer Commun (Lond); 2021 Mar; 41(3):218-228. PubMed ID: 33630411
[TBL] [Abstract] [Full Text] [Related]
10. Clinical characteristics and prognostic implications of BRCA-associated tumors in males: a pan-tumor survey.
Sun P; Li Y; Chao X; Li J; Luo R; Li M; He J
BMC Cancer; 2020 Oct; 20(1):994. PubMed ID: 33054725
[TBL] [Abstract] [Full Text] [Related]
11. External Evaluation of 3 Commercial Artificial Intelligence Algorithms for Independent Assessment of Screening Mammograms.
Salim M; Wåhlin E; Dembrower K; Azavedo E; Foukakis T; Liu Y; Smith K; Eklund M; Strand F
JAMA Oncol; 2020 Oct; 6(10):1581-1588. PubMed ID: 32852536
[TBL] [Abstract] [Full Text] [Related]
12. Incidence of second malignancies in individuals diagnosed with malignant peripheral nerve sheath tumors.
Williams LA; Moertel CL; Richardson M; Marcotte EL
J Neurooncol; 2020 May; 147(3):701-709. PubMed ID: 32239432
[TBL] [Abstract] [Full Text] [Related]
13. Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With breast cancer.
Kurian AW; Ward KC; Abrahamse P; Hamilton AS; Deapen D; Morrow M; Jagsi R; Katz SJ
JAMA Oncol; 2020 Apr; 6(4):e196400. PubMed ID: 32027353
[TBL] [Abstract] [Full Text] [Related]
14. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
[TBL] [Abstract] [Full Text] [Related]
15. Associations Between cancer Predisposition Testing Panel Genes and breast cancer.
Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS
JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444
[TBL] [Abstract] [Full Text] [Related]
16. breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
Uusitalo E; Kallionpää RA; Kurki S; Rantanen M; Pitkäniemi J; Kronqvist P; Härkönen P; Huovinen R; Carpen O; Pöyhönen M; Peltonen S; Peltonen J
Br J Cancer; 2017 Jan; 116(2):211-217. PubMed ID: 27931045
[TBL] [Abstract] [Full Text] [Related]
17. Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.
De Mattos-Arruda L; Weigelt B; Cortes J; Won HH; Ng CKY; Nuciforo P; Bidard FC; Aura C; Saura C; Peg V; Piscuoglio S; Oliveira M; Smolders Y; Patel P; Norton L; Tabernero J; Berger MF; Seoane J; Reis-Filho JS
Ann Oncol; 2014 Sep; 25(9):1729-1735. PubMed ID: 25009010
[TBL] [Abstract] [Full Text] [Related]
18. nf1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies.
Ponti G; Martorana D; Pellacani G; Ruini C; Loschi P; Baccarani A; De Santis G; Pollio A; Neri TM; Mandel VD; Maiorana A; Maccio L; Maccaferri M; Tomasi A
Anticancer Res; 2014 Jun; 34(6):3021-30. PubMed ID: 24922668
[TBL] [Abstract] [Full Text] [Related]
19. Increased risk of breast cancer in women with nf1.
Madanikia SA; Bergner A; Ye X; Blakeley JO
Am J Med Genet A; 2012 Dec; 158A(12):3056-60. PubMed ID: 23165953
[TBL] [Abstract] [Full Text] [Related]
20. The use of ancestral haplotypes in the molecular diagnosis of familial breast cancer.
Frosk P; Burgess S; Dyck T; Jobse R; Spriggs EL
Genet Test; 2007; 11(3):208-15. PubMed ID: 17949280
[TBL] [Abstract] [Full Text] [Related]
[Next]
